A global, values-based, R&D-driven biopharmaceutical leader focused on innovation and patient care, with a strong U.S. presence and a legacy of over 235 years in advancing health solutions.
Cambridge
Boston
Massachusetts
Notice Date
October 1, 2025
January 1, 2026
July 31, 2026
Unavailable
More WARN Notices from
